SCOPUS 정보 검색 플랫폼

Volumn 213, Issue 8, 2016, Pages 1479-1496

Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis

(14) Shimizu, Takafumi a Kubovcakova, Lucia a Nienhold, Ronny a Zmajkovic, Jakub a Meyer, Sara C a Hao Shen, Hui a Geier, Florian b Dirnhofer, Stephan b Guglielmelli, Paola c Vannucchi, Alessandro M c Milosevic Feenstra, Jelena D d Kralovics, Robert d Orkin, Stuart H e,f,g Skoda, Radek C a

a UNIVERSITY HOSPITAL BASEL (Switzerland)

b UNIVERSITY HOSPITAL BASEL (Switzerland)

c UNIVERSITY OF FLORENCE (Italy)

d CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Vienna 1090 (Australia)

e BOSTON CHILDREN S HOSPITAL (United States)

f DANA FARBER CANCER INSTITUTE (United States)

g HARVARD MEDICAL SCHOOL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CHIMERA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; ERYTHROPOIESIS; EZH2 GENE; FEMALE; GENE; GENE EXPRESSION; GENE LOSS; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HMGA2 GENE; JAK2 V617F GENE; LIN28B GENE; MEGAKARYOCYTE ERYTHROID PROGENITOR; MEGAKARYOPOIESIS; MOUSE; MYELOFIBROSIS; MYELOPROLIFERATIVE NEOPLASM; NEUTROPHIL COUNT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REGULATOR GENE; RETROVIRIDAE; RNA SEQUENCE; STEM CELL EXPANSION; SURVIVAL; THROMBOCYTE COUNT; UPREGULATION; AMINO ACID SUBSTITUTION; ANIMAL; DEFICIENCY; GENETICS; HEMATOLOGIC DISEASE; METABOLISM; MISSENSE MUTATION; MUTANT MOUSE STRAIN; MYELOPROLIFERATIVE DISORDER; PATHOLOGY;

EZH2 PROTEIN, MOUSE; JAK2 PROTEIN, MOUSE; JANUS KINASE 2; TRANSCRIPTION FACTOR EZH2; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMALS; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; HEMATOLOGIC NEOPLASMS; JANUS KINASE 2; MICE; MICE, MUTANT STRAINS; MUTATION, MISSENSE; MYELOPROLIFERATIVE DISORDERS; TUMOR SUPPRESSOR PROTEINS;

EID: 84982976238 PISSN: 00221007 EISSN: 15409538 Source Type: Journal
DOI: 10.1084/jem.20151136 Document Type: Article

Times cited : (94)

References (47)

1
- 0344420249
- Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia
- Andrieux, J., J.L. Demory, B. Dupriez, S. Quief, I. Plantier, C. Roumier, F. Bauters, J.L. Laï, and J.P. Kerckaert. 2004. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer. 39:82-87. http://dx.doi.org/10.1002/gcc.10297
- (2004) Genes Chromosomes Cancer , vol.39 , pp. 82-87
- Andrieux, J.¹ Demory, J.L.² Dupriez, B.³ Quief, S.⁴ Plantier, I.⁵ Roumier, C.⁶ Bauters, F.⁷ Laï, J.L.⁸ Kerckaert, J.P.⁹

2
- 0035760303
- + cells in myelofibrosis with myeloid metaplasia
- + cells in myelofibrosis with myeloid metaplasia. Blood. 98:3249-3255. http://dx.doi.org/10.1182/blood.V98.12.3249
- (2001) Blood , vol.98 , pp. 3249-3255
- Barosi, G.¹ Viarengo, G.² Pecci, A.³ Rosti, V.⁴ Piaggio, G.⁵ Marchetti, M.⁶ Frassoni, F.⁷

3
- 20144363192
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
- Cancer Genome Project
- Baxter, E.J., L.M. Scott, P.J. Campbell, C. East, N. Fourouclas, S. Swanton, G.S. Vassiliou, A.J. Bench, E.M. Boyd, N. Curtin, et al. Cancer Genome Project. 2005. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 365:1054-1061. http://dx.doi.org/10.1016/S0140-6736(05)74230-6
- (2005) Lancet , vol.365 , pp. 1054-1061
- Baxter, E.J.¹ Scott, L.M.² Campbell, P.J.³ East, C.⁴ Fourouclas, N.⁵ Swanton, S.⁶ Vassiliou, G.S.⁷ Bench, A.J.⁸ Boyd, E.M.⁹ Curtin, N.¹⁰

4
- 79959794787
- Clinical effect of point mutations in myelodysplastic syndromes
- Bejar, R., K. Stevenson, O. Abdel-Wahab, N. Galili, B. Nilsson, G. Garcia-Manero, H. Kantarjian, A. Raza, R.L. Levine, D. Neuberg, and B.L. Ebert. 2011. Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. 364:2496-2506. http://dx.doi.org/10.1056/NEJMoa1013343
- (2011) N. Engl. J. Med , vol.364 , pp. 2496-2506
- Bejar, R.¹ Stevenson, K.² Abdel-Wahab, O.³ Galili, N.⁴ Nilsson, B.⁵ Garcia-Manero, G.⁶ Kantarjian, H.⁷ Raza, A.⁸ Levine, R.L.⁹ Neuberg, D.¹⁰ Ebert, B.L.¹¹

5
- 0001677717
- Controlling the false discovery rate: A practical and powerful approach to multiple testing
- Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289-300.
- (1995) J. R. Stat. Soc. Series B Stat. Methodol , vol.57 , pp. 289-300
- Benjamini, Y.¹ Hochberg, Y.²

6
- 84881460310
- The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells
- Copley, M.R., S. Babovic, C. Benz, D.J. Knapp, P.A. Beer, D.G. Kent, S. Wohrer, D.Q. Treloar, C. Day, K. Rowe, et al. 2013. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 15:916-925. http://dx.doi.org/10.1038/ncb2783
- (2013) Nat. Cell Biol , vol.15 , pp. 916-925
- Copley, M.R.¹ Babovic, S.² Benz, C.³ Knapp, D.J.⁴ Beer, P.A.⁵ Kent, D.G.⁶ Wohrer, S.⁷ Treloar, D.Q.⁸ Day, C.⁹ Rowe, K.¹⁰

7
- 84871809302
- STAR: ultrafast universal RNAseq aligner
- Dobin, A., C.A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski, S. Jha, P. Batut, M. Chaisson, and T.R. Gingeras. 2013. STAR: ultrafast universal RNAseq aligner. Bioinformatics. 29:15-21. http://dx.doi.org/10.1093/bioinformatics/bts635
- (2013) Bioinformatics , vol.29 , pp. 15-21
- Dobin, A.¹ Davis, C.A.² Schlesinger, F.³ Drenkow, J.⁴ Zaleski, C.⁵ Jha, S.⁶ Batut, P.⁷ Chaisson, M.⁸ Gingeras, T.R.⁹

8
- 77955085750
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- Ernst, T., A.J. Chase, J. Score, C.E. Hidalgo-Curtis, C. Bryant, A.V. Jones, K. Waghorn, K. Zoi, F.M. Ross, A. Reiter, et al. 2010. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42:722-726. http://dx.doi.org/10.1038/ng.621
- (2010) Nat. Genet , vol.42 , pp. 722-726
- Ernst, T.¹ Chase, A.J.² Score, J.³ Hidalgo-Curtis, C.E.⁴ Bryant, C.⁵ Jones, A.V.⁶ Waghorn, K.⁷ Zoi, K.⁸ Ross, F.M.⁹ Reiter, A.¹⁰

9
- 84929144040
- QuasR: quantification and annotation of short reads in R
- Gaidatzis, D., A. Lerch, F. Hahne, and M.B. Stadler. 2015. QuasR: quantification and annotation of short reads in R. Bioinformatics. 31:1130-1132. http://dx.doi.org/10.1093/bioinformatics/btu781
- (2015) Bioinformatics , vol.31 , pp. 1130-1132
- Gaidatzis, D.¹ Lerch, A.² Hahne, F.³ Stadler, M.B.⁴

10
- 77954069195
- A flexible R package for nonnegative matrix factorization
- Gaujoux, R., and C. Seoighe. 2010. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 11:367. http://dx.doi.org/10.1186/1471-2105-11-367
- (2010) BMC Bioinformatics , vol.11 , pp. 367
- Gaujoux, R.¹ Seoighe, C.²

11
- 84928348527
- Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
- Gerstung, M., A. Pellagatti, L. Malcovati, A. Giagounidis, M.G. Porta, M. Jädersten, H. Dolatshad, A. Verma, N.C. Cross, P. Vyas, et al. 2015. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nat. Commun. 6:5901. http://dx.doi.org/10.1038/ncomms6901
- (2015) Nat. Commun , vol.6 , pp. 5901
- Gerstung, M.¹ Pellagatti, A.² Malcovati, L.³ Giagounidis, A.⁴ Porta, M.G.⁵ Jädersten, M.⁶ Dolatshad, H.⁷ Verma, A.⁸ Cross, N.C.⁹ Vyas, P.¹⁰

12
- 15944401331
- In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis
- Göthert, J.R., S.E. Gustin, M.A. Hall, A.R. Green, B. Göttgens, D.J. Izon, and C.G. Begley. 2005. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood. 105:2724-2732. http://dx.doi.org/10.1182/blood-2004-08-3037
- (2005) Blood , vol.105 , pp. 2724-2732
- Göthert, J.R.¹ Gustin, S.E.² Hall, M.A.³ Green, A.R.⁴ Göttgens, B.⁵ Izon, D.J.⁶ Begley, C.G.⁷

13
- 81055126771
- EZH2 mutational status predicts poor survival in myelofibrosis
- Guglielmelli, P., F. Biamonte, J. Score, C. Hidalgo-Curtis, F. Cervantes, M. Maffioli, T. Fanelli, T. Ernst, N. Winkelman, A.V. Jones, et al. 2011. EZH2 mutational status predicts poor survival in myelofibrosis. Blood. 118:5227-5234. http://dx.doi.org/10.1182/blood-2011-06-363424
- (2011) Blood , vol.118 , pp. 5227-5234
- Guglielmelli, P.¹ Biamonte, F.² Score, J.³ Hidalgo-Curtis, C.⁴ Cervantes, F.⁵ Maffioli, M.⁶ Fanelli, T.⁷ Ernst, T.⁸ Winkelman, N.⁹ Jones, A.V.¹⁰

14
- 84856746717
- Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease
- Herrera-Merchan, A., L. Arranz, J.M. Ligos, A. de Molina, O. Dominguez, and S. Gonzalez. 2012. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat. Commun. 3:623. http://dx.doi.org/10.1038/ncomms1623
- (2012) Nat. Commun , vol.3 , pp. 623
- Herrera-Merchan, A.¹ Arranz, L.² Ligos, J.M.³ de Molina, A.⁴ Dominguez, O.⁵ Gonzalez, S.⁶

15
- 69949085080
- Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition
- Hirabayashi, Y., N. Suzki, M. Tsuboi, T.A. Endo, T. Toyoda, J. Shinga, H. Koseki, M. Vidal, and Y. Gotoh. 2009. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition. Neuron. 63:600-613. http://dx.doi.org/10.1016/j.neuron.2009.08.021
- (2009) Neuron , vol.63 , pp. 600-613
- Hirabayashi, Y.¹ Suzki, N.² Tsuboi, M.³ Endo, T.A.⁴ Toyoda, T.⁵ Shinga, J.⁶ Koseki, H.⁷ Vidal, M.⁸ Gotoh, Y.⁹

16
- 17844383458
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
- James, C., V. Ugo, J.P. Le Couédic, J. Staerk, F. Delhommeau, C. Lacout, L. Garçon, H. Raslova, R. Berger, A. Bennaceur-Griscelli, et al. 2005. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 434:1144-1148. http://dx.doi.org/10.1038/nature03546
- (2005) Nature , vol.434 , pp. 1144-1148
- James, C.¹ Ugo, V.² Le Couédic, J.P.³ Staerk, J.⁴ Delhommeau, F.⁵ Lacout, C.⁶ Garçon, L.⁷ Raslova, H.⁸ Berger, R.⁹ Bennaceur-Griscelli, A.¹⁰

17
- 33344469959
- The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
- Kamminga, L.M., L.V. Bystrykh, A. de Boer, S. Houwer, J. Douma, E. Weersing, B. Dontje, and G. de Haan. 2006. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood. 107:2170-2179. http://dx.doi.org/10.1182/blood-2005-09-3585
- (2006) Blood , vol.107 , pp. 2170-2179
- Kamminga, L.M.¹ Bystrykh, L.V.² de Boer, A.³ Houwer, S.⁴ Douma, J.⁵ Weersing, E.⁶ Dontje, B.⁷ de Haan, G.⁸

18
- 84890372480
- Somatic mutations of calreticulin in myeloproliferative neoplasms
- Klampfl, T., H. Gisslinger, A.S. Harutyunyan, H. Nivarthi, E. Rumi, J.D. Milosevic, N.C. Them, T. Berg, B. Gisslinger, D. Pietra, et al. 2013. Somatic mutations of calreticulin in myeloproliferative neoplasms. N. Engl. J. Med. 369:2379-2390. http://dx.doi.org/10.1056/NEJMoa1311347
- (2013) N. Engl. J. Med , vol.369 , pp. 2379-2390
- Klampfl, T.¹ Gisslinger, H.² Harutyunyan, A.S.³ Nivarthi, H.⁴ Rumi, E.⁵ Milosevic, J.D.⁶ Them, N.C.⁷ Berg, T.⁸ Gisslinger, B.⁹ Pietra, D.¹⁰

19
- 17644424955
- A gain-of-function mutation of JAK2 in myeloproliferative disorders
- Kralovics, R., F. Passamonti, A.S. Buser, S.S. Teo, R. Tiedt, J.R. Passweg, A. Tichelli, M. Cazzola, and R.C. Skoda. 2005. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352:1779-1790. http://dx.doi.org/10.1056/NEJMoa051113
- (2005) N. Engl. J. Med , vol.352 , pp. 1779-1790
- Kralovics, R.¹ Passamonti, F.² Buser, A.S.³ Teo, S.S.⁴ Tiedt, R.⁵ Passweg, J.R.⁶ Tichelli, A.⁷ Cazzola, M.⁸ Skoda, R.C.⁹

20
- 84874091669
- Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model
- Kubovcakova, L., P. Lundberg, J. Grisouard, H. Hao-Shen, V. Romanet, R. Andraos, M. Murakami, S. Dirnhofer, K.U. Wagner, T. Radimerski, and R.C. Skoda. 2013. Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model. Blood. 121:1188-1199. http://dx.doi.org/10.1182/blood-2012-03-415646
- (2013) Blood , vol.121 , pp. 1188-1199
- Kubovcakova, L.¹ Lundberg, P.² Grisouard, J.³ Hao-Shen, H.⁴ Romanet, V.⁵ Andraos, R.⁶ Murakami, M.⁷ Dirnhofer, S.⁸ Wagner, K.U.⁹ Radimerski, T.¹⁰ Skoda, R.C.¹¹

21
- 0029155706
- Inducible gene targeting in mice
- Kühn, R., F. Schwenk, M. Aguet, and K. Rajewsky. 1995. Inducible gene targeting in mice. Science. 269:1427-1429. http://dx.doi.org/10.1126/science.7660125
- (1995) Science , vol.269 , pp. 1427-1429
- Kühn, R.¹ Schwenk, F.² Aguet, M.³ Rajewsky, K.⁴

22
- 20244369569
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
- Levine, R.L., M. Wadleigh, J. Cools, B.L. Ebert, G. Wernig, B.J. Huntly, T.J. Boggon, I. Wlodarska, J.J. Clark, S. Moore, et al. 2005. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 7:387-397. http://dx.doi.org/10.1016/j.ccr.2005.03.023
- (2005) Cancer Cell , vol.7 , pp. 387-397
- Levine, R.L.¹ Wadleigh, M.² Cools, J.³ Ebert, B.L.⁴ Wernig, G.⁵ Huntly, B.J.⁶ Boggon, T.J.⁷ Wlodarska, I.⁸ Clark, J.J.⁹ Moore, S.¹⁰

23
- 79956096380
- Mouse models of myeloproliferative neoplasms: JAK of all grades
- Li, J., D.G. Kent, E. Chen, and A.R. Green. 2011. Mouse models of myeloproliferative neoplasms: JAK of all grades. Dis. Model. Mech. 4:311-317. http://dx.doi.org/10.1242/dmm.006817
- (2011) Dis. Model. Mech , vol.4 , pp. 311-317
- Li, J.¹ Kent, D.G.² Chen, E.³ Green, A.R.⁴

24
- 84899065964
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- Lundberg, P., A. Karow, R. Nienhold, R. Looser, H. Hao-Shen, I. Nissen, S. Girsberger, T. Lehmann, J. Passweg, M. Stern, et al. 2014a. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 123:2220-2228. http://dx.doi.org/10.1182/blood-2013-11-537167
- (2014) Blood , vol.123 , pp. 2220-2228
- Lundberg, P.¹ Karow, A.² Nienhold, R.³ Looser, R.⁴ Hao-Shen, H.⁵ Nissen, I.⁶ Girsberger, S.⁷ Lehmann, T.⁸ Passweg, J.⁹ Stern, M.¹⁰

25
- 84908258893
- Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
- Lundberg, P., H. Takizawa, L. Kubovcakova, G. Guo, H. Hao-Shen, S. Dirnhofer, S.H. Orkin, M.G. Manz, and R.C. Skoda. 2014b. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F. J. Exp. Med. 211:2213-2230. http://dx.doi.org/10.1084/jem.20131371
- (2014) J. Exp. Med , vol.211 , pp. 2213-2230
- Lundberg, P.¹ Takizawa, H.² Kubovcakova, L.³ Guo, G.⁴ Hao-Shen, H.⁵ Dirnhofer, S.⁶ Orkin, S.H.⁷ Manz, M.G.⁸ Skoda, R.C.⁹

26
- 77956282774
- Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells
- Majewski, I.J., M.E. Ritchie, B. Phipson, J. Corbin, M. Pakusch, A. Ebert, M. Busslinger, H. Koseki, Y. Hu, G.K. Smyth, et al. 2010. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood. 116:731-739. http://dx.doi.org/10.1182/blood-2009-12-260760
- (2010) Blood , vol.116 , pp. 731-739
- Majewski, I.J.¹ Ritchie, M.E.² Phipson, B.³ Corbin, J.⁴ Pakusch, M.⁵ Ebert, A.⁶ Busslinger, M.⁷ Koseki, H.⁸ Hu, Y.⁹ Smyth, G.K.¹⁰

27
- 78751662908
- The Polycomb complex PRC2 and its mark in life
- Margueron, R., and D. Reinberg. 2011. The Polycomb complex PRC2 and its mark in life. Nature. 469:343-349. http://dx.doi.org/10.1038/nature09784
- (2011) Nature , vol.469 , pp. 343-349
- Margueron, R.¹ Reinberg, D.²

28
- 84858041341
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
- McCarthy, D.J., Y. Chen, and G.K. Smyth. 2012. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40:4288-4297. http://dx.doi.org/10.1093/nar/gks042
- (2012) Nucleic Acids Res , vol.40 , pp. 4288-4297
- McCarthy, D.J.¹ Chen, Y.² Smyth, G.K.³

29
- 84055218931
- Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells
- Mochizuki-Kashio, M., Y. Mishima, S. Miyagi, M. Negishi, A. Saraya, T. Konuma, J. Shinga, H. Koseki, and A. Iwama. 2011. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Blood. 118:6553-6561. http://dx.doi.org/10.1182/blood-2011-03-340554
- (2011) Blood , vol.118 , pp. 6553-6561
- Mochizuki-Kashio, M.¹ Mishima, Y.² Miyagi, S.³ Negishi, M.⁴ Saraya, A.⁵ Konuma, T.⁶ Shinga, J.⁷ Koseki, H.⁸ Iwama, A.⁹

30
- 75749124332
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- Morin, R.D., N.A. Johnson, T.M. Severson, A.J. Mungall, J. An, R. Goya, J.E. Paul, M. Boyle, B.W. Woolcock, F. Kuchenbauer, et al. 2010. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42:181-185. http://dx.doi.org/10.1038/ng.518
- (2010) Nat. Genet , vol.42 , pp. 181-185
- Morin, R.D.¹ Johnson, N.A.² Severson, T.M.³ Mungall, A.J.⁴ An, J.⁵ Goya, R.⁶ Paul, J.E.⁷ Boyle, M.⁸ Woolcock, B.W.⁹ Kuchenbauer, F.¹⁰

31
- 84890328032
- Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
- Nangalia, J., C.E. Massie, E.J. Baxter, F.L. Nice, G. Gundem, D.C. Wedge, E. Avezov, J. Li, K. Kollmann, D.G. Kent, et al. 2013. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N. Engl. J. Med. 369:2391-2405. http://dx.doi.org/10.1056/NEJMoa1312542
- (2013) N. Engl. J. Med , vol.369 , pp. 2391-2405
- Nangalia, J.¹ Massie, C.E.² Baxter, E.J.³ Nice, F.L.⁴ Gundem, G.⁵ Wedge, D.C.⁶ Avezov, E.⁷ Li, J.⁸ Kollmann, K.⁹ Kent, D.G.¹⁰

32
- 84859475727
- Polycomb repressive complex 2 is required for MLL-AF9 leukemia
- Neff, T., A.U. Sinha, M.J. Kluk, N. Zhu, M.H. Khattab, L. Stein, H. Xie, S.H. Orkin, and S.A. Armstrong. 2012. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc. Natl. Acad. Sci. USA. 109:5028-5033. http://dx.doi.org/10.1073/pnas.1202258109
- (2012) Proc. Natl. Acad. Sci. USA , vol.109 , pp. 5028-5033
- Neff, T.¹ Sinha, A.U.² Kluk, M.J.³ Zhu, N.⁴ Khattab, M.H.⁵ Stein, L.⁶ Xie, H.⁷ Orkin, S.H.⁸ Armstrong, S.A.⁹

33
- 0034977239
- The polycomb-group gene Ezh2 is required for early mouse development
- O'Carroll, D., S. Erhardt, M. Pagani, S.C. Barton, M.A. Surani, and T. Jenuwein. 2001. The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell. Biol. 21:4330-4336. http://dx.doi.org/10.1128/MCB.21.13.4330-4336.2001
- (2001) Mol. Cell. Biol , vol.21 , pp. 4330-4336
- O'Carroll, D.¹ Erhardt, S.² Pagani, M.³ Barton, S.C.⁴ Surani, M.A.⁵ Jenuwein, T.⁶

34
- 84860364648
- Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes
- Oguro, H., J. Yuan, S. Tanaka, S. Miyagi, M. Mochizuki-Kashio, H. Ichikawa, S. Yamazaki, H. Koseki, H. Nakauchi, and A. Iwama. 2012. Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes. J. Exp. Med. 209:445-454. http://dx.doi.org/10.1084/jem.20111709
- (2012) J. Exp. Med , vol.209 , pp. 445-454
- Oguro, H.¹ Yuan, J.² Tanaka, S.³ Miyagi, S.⁴ Mochizuki-Kashio, M.⁵ Ichikawa, H.⁶ Yamazaki, S.⁷ Koseki, H.⁸ Nakauchi, H.⁹ Iwama, A.¹⁰

35
- 33750534561
- MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
- Pardanani, A.D., R.L. Levine, T. Lasho, Y. Pikman, R.A. Mesa, M. Wadleigh, D.P. Steensma, M.A. Elliott, A.P. Wolanskyj, W.J. Hogan, et al. 2006. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 108:3472-3476. http://dx.doi.org/10.1182/blood-2006-04-018879
- (2006) Blood , vol.108 , pp. 3472-3476
- Pardanani, A.D.¹ Levine, R.L.² Lasho, T.³ Pikman, Y.⁴ Mesa, R.A.⁵ Wadleigh, M.⁶ Steensma, D.P.⁷ Elliott, M.A.⁸ Wolanskyj, A.P.⁹ Hogan, W.J.¹⁰

36
- 33746437130
- MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
- Pikman, Y., B.H. Lee, T. Mercher, E. McDowell, B.L. Ebert, M. Gozo, A. Cuker, G. Wernig, S. Moore, I. Galinsky, et al. 2006. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 3:e270. http://dx.doi.org/10.1371/journal.pmed.0030270
- (2006) PLoS Med , vol.3 , pp. e270
- Pikman, Y.¹ Lee, B.H.² Mercher, T.³ McDowell, E.⁴ Ebert, B.L.⁵ Gozo, M.⁶ Cuker, A.⁷ Wernig, G.⁸ Moore, S.⁹ Galinsky, I.¹⁰

37
- 81855183636
- Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms
- Piskounova, E., C. Polytarchou, J.E. Thornton, R.J. LaPierre, C. Pothoulakis, J.P. Hagan, D. Iliopoulos, and R.I. Gregory. 2011. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell. 147:1066-1079. http://dx.doi.org/10.1016/j.cell.2011.10.039
- (2011) Cell , vol.147 , pp. 1066-1079
- Piskounova, E.¹ Polytarchou, C.² Thornton, J.E.³ LaPierre, R.J.⁴ Pothoulakis, C.⁵ Hagan, J.P.⁶ Iliopoulos, D.⁷ Gregory, R.I.⁸

38
- 77956222562
- Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer
- Sauvageau, M., and G. Sauvageau. 2010. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell. 7:299-313. http://dx.doi.org/10.1016/j.stem.2010.08.002
- (2010) Cell Stem Cell , vol.7 , pp. 299-313
- Sauvageau, M.¹ Sauvageau, G.²

39
- 0035894949
- + T-cell/ dendritic cell interactions in vivo
- + T-cell/ dendritic cell interactions in vivo. Cell. Immunol. 214:110-122. http://dx.doi.org/10.1006/cimm.2001.1895
- (2001) Cell. Immunol , vol.214 , pp. 110-122
- Schaefer, B.C.¹ Schaefer, M.L.² Kappler, J.W.³ Marrack, P.⁴ Kedl, R.M.⁵

40
- 69249104612
- The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos
- Tefferi, A., J. Thiele, and J.W. Vardiman. 2009. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 115:3842-3847. http://dx.doi.org/10.1002/cncr.24440
- (2009) Cancer , vol.115 , pp. 3842-3847
- Tefferi, A.¹ Thiele, J.² Vardiman, J.W.³

41
- 43249084493
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- Tiedt, R., H. Hao-Shen, M.A. Sobas, R. Looser, S. Dirnhofer, J. Schwaller, and R.C. Skoda. 2008. Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood. 111:3931-3940. http://dx.doi.org/10.1182/blood-2007-08-107748
- (2008) Blood , vol.111 , pp. 3931-3940
- Tiedt, R.¹ Hao-Shen, H.² Sobas, M.A.³ Looser, R.⁴ Dirnhofer, S.⁵ Schwaller, J.⁶ Skoda, R.C.⁷

42
- 80051931772
- New mutations and pathogenesis of myeloproliferative neoplasms
- Vainchenker, W., F. Delhommeau, S.N. Constantinescu, and O.A. Bernard. 2011. New mutations and pathogenesis of myeloproliferative neoplasms. Blood. 118:1723-1735. http://dx.doi.org/10.1182/blood-2011-02-292102
- (2011) Blood , vol.118 , pp. 1723-1735
- Vainchenker, W.¹ Delhommeau, F.² Constantinescu, S.N.³ Bernard, O.A.⁴

43
- 70349256226
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- Vardiman, J.W., J. Thiele, D.A. Arber, R.D. Brunning, M.J. Borowitz, A. Porwit, N.L. Harris, M.M. Le Beau, E. Hellström-Lindberg, A. Tefferi, and C.D. Bloomfield. 2009. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 114:937-951. http://dx.doi.org/10.1182/blood-2009-03-209262
- (2009) Blood , vol.114 , pp. 937-951
- Vardiman, J.W.¹ Thiele, J.² Arber, D.A.³ Brunning, R.D.⁴ Borowitz, M.J.⁵ Porwit, A.⁶ Harris, N.L.⁷ Le Beau, M.M.⁸ Hellström-Lindberg, E.⁹ Tefferi, A.¹⁰ Bloomfield, C.D.¹¹

44
- 40849108663
- Selective blockade of microRNA processing by Lin28
- Viswanathan, S.R., G.Q. Daley, and R.I. Gregory. 2008. Selective blockade of microRNA processing by Lin28. Science. 320:97-100. http://dx.doi.org/10.1126/science.1154040
- (2008) Science , vol.320 , pp. 97-100
- Viswanathan, S.R.¹ Daley, G.Q.² Gregory, R.I.³

45
- 67649881121
- Lin28 promotes transformation and is associated with advanced human malignancies
- Viswanathan, S.R., J.T. Powers, W. Einhorn, Y. Hoshida, T.L. Ng, S. Toffanin, M. O'Sullivan, J. Lu, L.A. Phillips, V.L. Lockhart, et al. 2009. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 41:843-848. http://dx.doi.org/10.1038/ng.392
- (2009) Nat. Genet , vol.41 , pp. 843-848
- Viswanathan, S.R.¹ Powers, J.T.² Einhorn, W.³ Hoshida, Y.⁴ Ng, T.L.⁵ Toffanin, S.⁶ O'Sullivan, M.⁷ Lu, J.⁸ Phillips, L.A.⁹ Lockhart, V.L.¹⁰

46
- 84891740118
- Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner
- Xie, H., J. Xu, J.H. Hsu, M. Nguyen, Y. Fujiwara, C. Peng, and S.H. Orkin. 2014. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell. 14:68-80. http://dx.doi.org/10.1016/j.stem.2013.10.001
- (2014) Cell Stem Cell , vol.14 , pp. 68-80
- Xie, H.¹ Xu, J.² Hsu, J.H.³ Nguyen, M.⁴ Fujiwara, Y.⁵ Peng, C.⁶ Orkin, S.H.⁷

47
- 79952167230
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
- Yap, D.B., J. Chu, T. Berg, M. Schapira, S.W. Cheng, A. Moradian, R.D. Morin, A.J. Mungall, B. Meissner, M. Boyle, et al. 2011. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood. 117:2451-2459. http://dx.doi.org/10.1182/blood-2010-11-321208
- (2011) Blood , vol.117 , pp. 2451-2459
- Yap, D.B.¹ Chu, J.² Berg, T.³ Schapira, M.⁴ Cheng, S.W.⁵ Moradian, A.⁶ Morin, R.D.⁷ Mungall, A.J.⁸ Meissner, B.⁹ Boyle, M.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.